Ardem Patapoutian

Scripps Research Institute

Ardem Patapoutian leads a mechanotransduction laboratory at Scripps Research, where his Howard Hughes Medical Institute team answered a century-old puzzle: which molecules let cells feel physical force. Born in Beirut and educated at UCLA and Caltech, Patapoutian devised an expression-cloning screen that systematically silenced candidate genes in a mechanically responsive cell line until the touch-evoked current vanished, pinpointing PIEZO1 and PIEZO2 as the missing force sensors. Those trimeric channels, joined by his earlier identification of the cold-and-menthol detector TRPM8, converted an abstract sensory question into tractable molecular biology and brought him a shared 2021 Nobel laureateship in medicine. The PIEZO breakthrough launched mechanobiology as its own discipline, clarifying at the level of single proteins how bodies register gentle touch, limb position, lung inflation, bladder fullness, and the shear forces inside flowing blood. PIEZO2 mutations were soon tied to inherited disorders of proprioception and touch, while PIEZO1 emerged as a regulator of vascular tone, lymphatic development, iron metabolism, and red-blood-cell volume, linking the channel to hereditary xerocytosis and to anemia phenotypes. The Patapoutian laboratory has gone on to resolve the curved, propeller-shaped cryo-EM architecture of PIEZO trimers and to dissect how membrane tension gates them, while screening for small molecules that open or block the channels as candidate analgesics. Earlier in his career he led large-scale functional genomics screens of the TRP channel superfamily, cataloguing the thermosensors that report cold, warmth, and chemical irritants. Patapoutian also co-founded efforts spinning mechanobiology insights toward pain and cardiovascular therapeutics, and his recruitment, training, and Howard Hughes funding have seeded a generation of mechanotransduction labs now studying how force shapes physiology from the gut to the bloodstream.